Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

LIU Li-hua, OU Zhou-luo, Zhu, Chun-fang. Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats[J]. Journal of Pharmaceutical Practice and Service, 2004, (3): 138-140.
Citation: LIU Li-hua, OU Zhou-luo, Zhu, Chun-fang. Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats[J]. Journal of Pharmaceutical Practice and Service, 2004, (3): 138-140.

Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats

  • Received Date: 2003-12-29
  • Objective To observe the effect of a novel liposome-prednisolone on puromycin aminonucleoside (PAN) nephropathy model in rats. Methods 160~180g BW male Wistar rats were used in this experiment. The rats were given a single injection of PAN at the dose of 4mg/100g BW through right jugular vein to establish the nephrotic syndrome (NS) model. The free prednisolone (PRED) treated group were given (i.p.) the free prednisolone at the dose of 2.0mg/100g BW and the liposome prednisolone (Lipo-PRED) treated group were given (i.v.) the liposome prednisolone at the dose of 1.5mg/100g BW. Urinary protein excretion examined with the biuret method and the monocyte/macrophage, CD4+ T cells and CD8+T cells were analyzed by immunohistochemistry. Results The proteinuria of the Lipo-PRED treated group reduced; the infiltration of monocyte/macrophages, CD4+T cells and CD8+T cells in the glomeruli and interstitium also remarkably weakened. Conclusion The liposome prednisolone can remarkably reduce the proteinuria excretion and leukocyte infiltration both in the glomeruli and tubulointerstitium in the PAN model.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2059) PDF downloads(874) Cited by()

Related
Proportional views

Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats

Abstract: Objective To observe the effect of a novel liposome-prednisolone on puromycin aminonucleoside (PAN) nephropathy model in rats. Methods 160~180g BW male Wistar rats were used in this experiment. The rats were given a single injection of PAN at the dose of 4mg/100g BW through right jugular vein to establish the nephrotic syndrome (NS) model. The free prednisolone (PRED) treated group were given (i.p.) the free prednisolone at the dose of 2.0mg/100g BW and the liposome prednisolone (Lipo-PRED) treated group were given (i.v.) the liposome prednisolone at the dose of 1.5mg/100g BW. Urinary protein excretion examined with the biuret method and the monocyte/macrophage, CD4+ T cells and CD8+T cells were analyzed by immunohistochemistry. Results The proteinuria of the Lipo-PRED treated group reduced; the infiltration of monocyte/macrophages, CD4+T cells and CD8+T cells in the glomeruli and interstitium also remarkably weakened. Conclusion The liposome prednisolone can remarkably reduce the proteinuria excretion and leukocyte infiltration both in the glomeruli and tubulointerstitium in the PAN model.

LIU Li-hua, OU Zhou-luo, Zhu, Chun-fang. Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats[J]. Journal of Pharmaceutical Practice and Service, 2004, (3): 138-140.
Citation: LIU Li-hua, OU Zhou-luo, Zhu, Chun-fang. Therapeutic effect of a new liposome-prednisolone on the puromycin aminonucleoside nephropathy in rats[J]. Journal of Pharmaceutical Practice and Service, 2004, (3): 138-140.

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return